Clinical Diagnosis

Latest News


CME Content


Baltimore-Race, that ever-sensitive subject in American culture, was the focus of a day-long meeting, "Ethnicity & Glaucoma: The Past, Present, and Future," at Johns Hopkins' Bloomberg School of Public Health.

Fort Lauderdale, FL-Estrogen-whether endogenous or from hormone replacement therapy (HRT)-appears to help prevent cataract formation, according to Australian researcher Christine Younan, MD, who reported her findings at the annual meeting of the Association for Research in Vision and Ophthalmology.

New York-The official definition of glaucoma has changed over the years to downplay the role of IOP, although IOP does remain a central issue in the treatment and prevention of the condition. Such was the conclusion drawn from discussions at the Glaucoma 2002 meeting here.

San Antonio, TX-Before prescribing one of the newer medications for glaucoma, clinicians should ask what drugs the patient may be taking for aches and pains-especially non-steroidal anti-inflammatory agents (NSAIDs), including something as innocuous as aspirin, said William E. Sponsel, MD.

Boston-The incidence of overcorrection following PRK and LASIK is fortunately very small, generally less than 5%. Unfortunately, the incidence of consecutive hyperopia after RK is significantly greater and, over time, becomes higher with a hyperopic shift, said Helen K. Wu, MD.

A genetically engineered molecule designed to kill cancers by destroying their rapidly growing blood vessels offers a new line of attack against age-related macular degeneration (AMD) and other retinal conditions, said Alan Garen, PhD.

New Orleans-A system incorporating a narrow-beam excimer laser with an active tracking system to detect minuscule eye motions is effective in the LASIK correction of myopia and astigmatism, according to Marguerite B. McDonald, MD, clinical professor of ophthalmology at Tulane University School of Medicine here.

San Francisco-Levofloxacin (Quixin, Santen)-the new kid in the fluoroquinolone family-is less likely to encounter resistant strains of bacteria than the two older members of that antibiotic family, ofloxacin (Ocuflox, Allergan) and ciprofloxacin (Ciloxan, Alcon), according to David Hwang, MD.

New York-The short-term elevated IOP that takes place when a microkeratome suction ring is applied to the eye during LASIK does not damage the retinal nerve fiber layer (NFL), according to New York researchers.

Farmington, CT-A newly discovered gene provides at least a partial solution to the puzzle of normal-tension glaucoma, according to Mansoor Sarfarazi, PhD.

A test for the optineurin gene will be available to ophthalmologists soon - possibly this year and certainly by 2003, said S. Kumar Chandrasekaran, PhD, CEO of InSite Vision, Alameda, CA.

Portland, OR-Hormone replacement therapy (HRT) does not appear to alter the incidence of dry eye symptoms or physiologic dry eye in women prior to or during menopause, according to Oregon researchers.

Philadelphia-A case-control study-in which each patient served as his or her own control-found that a single-piece lens may be less likely to cause vision-troubling capsular striae than a multipiece lens, said Richard Tipperman, MD.

Galveston, TX-Three-times-a-day treatment with famciclovir (Famvir, Novartis) was as effective against ophthalmic herpes zoster as five-times-a-day acyclovir (Zovirax, Glaxo Wellcome) in a major international trial, said Stephen K. Tyring, MD, PhD.

Houston-An artificial retina could be the answer for an estimated 1 million Americans with retinal blindness by conditions such as retinitis pigmentosa and age-related macular degeneration, said Alex Ignatiev, PhD, professor of physics, chemistry, and electrical and computer engineering at the University of Houston.

Allowing patients to listen to the music of their choiceduring cataract or glaucoma surgery can help reduce the cardiovascular effectscaused by both pre- and peri-operative feelings of stress, according toKaren Allen, PhD.

Augusta, GA-Despite negative results in an early trial, effortsare continuing to determine whether external-beam irradiation can slow visionloss caused by subfoveal choroidal neovascularization (CNV) in age-relatedmacular degeneration (AMD), said Dennis M. Marcus, MD.